Karyopharm to Participate at the 2026 Jefferies Global Healthcare Conference

Karyopharm (Nasdaq: KPTI) announced that senior management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026, at 8:10 a.m. ET in New York.

Rhea-AI Summary

Karyopharm (Nasdaq: KPTI) announced that senior management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026, at 8:10 a.m. ET in New York.

A live webcast and replay will be available in the Investors & Media section of Karyopharm's website.

Argus May 28 session

+1.45% close to close Open Argus

Details

News Market Reaction – KPTI

On May 28, the day this news came out, KPTI closed 1.45% above the previous close.

Data tracked by StockTitan Argus for the May 28 session.

Key Figures

Conference date: June 4, 2026 Conference time: 8:10 a.m. ET Registered shares: 8,843,036 shares +2 more

Conference date

June 4, 2026

Jefferies Global Healthcare Conference fireside chat

Conference time

8:10 a.m. ET

Scheduled start of Jefferies fireside chat

Registered shares

8,843,036 shares

Resale registration statement related to March 2026 private placement

Private placement proceeds

$30 million

Gross proceeds from March 2026 financing referenced in shelf summary

Ownership limit

9.99%

Beneficial ownership cap on warrant exercises in shelf registration

Historical Context

5 past events · Latest: May 14

5 events

1. May 14

   Earnings & trials

   24h Move

   +0.6%

   Q1 2026 results plus completion of Phase 3 endometrial cancer trial enrollment.

2. May 12

   Investor conferences

   24h Move

   +1.2%

   Announcement of participation in two May 2026 investor conference fireside chats.

3. May 07

   Earnings date notice

   24h Move

   -1.9%

   Scheduling notice for Q1 2026 earnings call and webcast on May 14, 2026.

4. Apr 21

   Clinical presentation

   24h Move

   +2.6%

   Phase 3 SENTRY myelofibrosis data selected as late-breaking oral at ASCO 2026.

5. Mar 24

   Private placement

   24h Move

   -18.3%

   $30M private placement with additional warrants funding operations into late Q3 2026.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEWTON, Mass., May 28, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate at the 2026 Jefferies Global Healthcare Conference in a fireside chat on Thursday, June 4, 2026 at 8:10 a.m. ET in New York, NY.

A live webcast of the fireside chat can be accessed under "Events & Presentations" in the Investors & Media section of the Company's website, http://investors.karyopharm.com/events-presentations, and will be available for replay following the event.

About Karyopharm Therapeutics

Karyopharm Therapeutics is a commercial-stage pharmaceutical company pioneering the science of nuclear export inhibition to develop differentiated therapies for patients with cancer. The Company's lead therapy, XPOVIO® (selinexor), is a first-in-class inhibitor of exportin 1 (XPO1). XPOVIO is marketed by the Company in the U.S. for adults with relapsed or refractory multiple myeloma and is approved as XPOVIO or NEXPOVIO® in more than 50 ex-U.S. countries and territories. Building on its leadership in XPO1 biology, Karyopharm is advancing selinexor's potential in hematologic and solid tumor cancers, including in myelofibrosis and TP53 wild-type endometrial cancer. The Company is also exploring opportunities to evaluate XPO1 inhibition across myeloproliferative neoplasms and TP53 wild-type driven solid tumors using next-generation compounds, including eltanexor. Headquartered in Newton, Massachusetts, Karyopharm has an established, efficient and scalable commercial infrastructure to bring novel therapeutic options to patients with cancer. For more information, visit www.karyopharm.com, and follow us on LinkedIn and on X at @Karyopharm.

XPOVIO^® and NEXPOVIO^® are registered trademarks of Karyopharm Therapeutics Inc.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/karyopharm-to-participate-at-the-2026-jefferies-global-healthcare-conference-302783532.html

SOURCE Karyopharm Therapeutics Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Karyopharm (Nasdaq: KPTI) present at the 2026 Jefferies Global Healthcare Conference?

Karyopharm will present a fireside chat on June 4, 2026, at 8:10 a.m. ET. According to Karyopharm, the session features senior management and will take place in New York, offering investors insights into the company’s ongoing activities.

How can investors access the Karyopharm (KPTI) webcast from the 2026 Jefferies Global Healthcare Conference?

Investors can access the live Karyopharm webcast via the Investors & Media section of its website. According to Karyopharm, the fireside chat will appear under “Events & Presentations” and a replay will remain available online following the conference event.

Will a replay of Karyopharm's 2026 Jefferies Global Healthcare Conference fireside chat be available?

Yes, a replay of Karyopharm’s fireside chat will be available after the event. According to Karyopharm, investors can find it under “Events & Presentations” in the Investors & Media section of the company’s investor relations website for on-demand viewing.

What type of session will Karyopharm (KPTI) hold at the 2026 Jefferies Global Healthcare Conference?

Karyopharm will participate in a fireside chat format at the conference. According to Karyopharm, the company’s senior management team will take part in this discussion, giving investors an opportunity to hear management commentary on the business in a conversational setting.

Where on Karyopharm's website can the 2026 Jefferies Global Healthcare Conference webcast be found?

The webcast can be found in the Investors & Media section of Karyopharm’s website. According to Karyopharm, investors should navigate to the “Events & Presentations” page, where both the live stream and replay of the fireside chat will be posted.